James Aloysius Brady does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Verona Pharma plc, and Xeris Biopharma Holdings, Inc..

2025 was James Aloysius Brady's most active year for acquiring shares with 4 total transactions. James Aloysius Brady's most active month to acquire stocks was the month of March. 2025 was James Aloysius Brady's most active year for disposing of shares, totalling 8 transactions. James Aloysius Brady's most active month to dispose stocks was the month of September. 2022 saw James Aloysius Brady paying a total of $0.00 for 288,000 shares, this is the most they've acquired in one year. In 2026 James Aloysius Brady cashed out on 10,834 shares for a total of $60,035.53, their largest year based on trade value.